HSBC Holdings Portfolio holdings
HSBC Holdings plc, founded in 1865 as the Hongkong and Shanghai Banking Corporation by Sir Thomas Sutherland to finance trade in East Asia, is a British multinational bank headquartered in London, managing trillions in assets as one of the world’s largest banking and financial services organizations. Operating in over 60 countries with a strong emphasis on Asia—where it generates much of its revenue—HSBC offers retail banking, wealth management, commercial banking, and global markets services to more than 40 million customers, supported by around 214,000 employees as of late 2024. Known for its international network and resilience through crises like the 1997 Asian financial downturn, HSBC has pivoted under Group CEO Noel Quinn (since 2020) to accelerate digital transformation and sustainability goals, targeting net-zero emissions by 2050. Despite challenges like geopolitical tensions and regulatory pressures, HSBC remains a cornerstone of global finance, leveraging its heritage as a trade financier into a modern, Asia-centric banking powerhouse.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$511M |
| 2 |
Microsoft
MSFT
|
+$322M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$305M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$263M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$239M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$2.99B |
| 2 |
ONC
BeOne Medicines Ltd
ONC
|
+$115M |
| 3 |
General Dynamics
GD
|
+$90.3M |
| 4 |
Advanced Micro Devices
AMD
|
+$82.8M |
| 5 |
Stellantis
STLA
|
+$76.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.27% |
| 2 | Consumer Discretionary | 15.55% |
| 3 | Financials | 10.39% |
| 4 | Healthcare | 9.73% |
| 5 | Communication Services | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GAN
2426
DELISTED
GAN Ltd
GAN
| $367K | ﹤0.01% |
18,147
+2,503
| +16% | +$41.9K |
|
2427
Ironwood Pharmaceuticals
IRWD
$696M
| $367K | ﹤0.01% |
32,236
+16,096
| +100% | +$176K |
|
2428
Immunovant
IMVT
$7.93B
| $366K | ﹤0.01% |
7,899
-5,221
| -40% | -$241K |
|
2429
PRA Group
PRAA
$663M
| $366K | ﹤0.01% |
9,292
+4,242
| +84% | +$168K |
|
|
REVG
2430
DELISTED
REV Group
REVG
| $366K | ﹤0.01% |
41,499
-7,152
| -15% | -$63.7K |
|
|
KAMN
2431
DELISTED
Kaman Corp
KAMN
| $366K | ﹤0.01% |
+6,405
| New | +$315K |
|
2432
iShares MSCI BIC ETF
BKF
$78.1M
| $365K | ﹤0.01% |
7,000
| – | – |
|
|
FARO
2433
DELISTED
Faro Technologies
FARO
| $365K | ﹤0.01% |
+5,223
| New | +$345K |
|
2434
ICF International
ICFI
$1.46B
| $365K | ﹤0.01% |
4,957
-2,471
| -33% | -$178K |
|
|
VBIV
2435
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $365K | ﹤0.01% |
+4,409
| New | +$376K |
|
2436
Stratasys
SSYS
$679M
| $364K | ﹤0.01% |
17,529
+4,424
| +34% | +$71K |
|
2437
ICL Group
ICL
$6.53B
| $362K | ﹤0.01% |
71,079
+33,019
| +87% | +$138K |
|
2438
CALL
Simon Property Group
SPG
$74.4B
| $362K | ﹤0.01% |
4,300
-20,700
| -83% | -$1.58M |
|
|
VXRT
2439
DELISTED
Vaxart
VXRT
| $362K | ﹤0.01% |
+63,391
| New | +$403K |
|
|
LTHM
2440
DELISTED
Livent Corporation
LTHM
| $362K | ﹤0.01% |
19,075
-40,946
| -68% | -$571K |
|
2441
Compass Minerals
CMP
$1.23B
| $361K | ﹤0.01% |
+5,829
| New | +$361K |
|
2442
KB Home
KBH
$3.37B
| $361K | ﹤0.01% |
+10,692
| New | +$384K |
|
2443
Civista Bancshares
CIVB
$604M
| $360K | ﹤0.01% |
20,473
+389
| +2% | +$6.15K |
|
|
RP
2444
DELISTED
RealPage, Inc.
RP
| $360K | ﹤0.01% |
+4,135
| New | +$271K |
|
2445
Huntsman Corp
HUN
$1.71B
| $359K | ﹤0.01% |
14,234
-8,959
| -39% | -$222K |
|
|
MSGN
2446
DELISTED
MSG Networks Inc.
MSGN
| $359K | ﹤0.01% |
24,569
-2
| -0% | -$22 |
|
2447
Cavco Industries
CVCO
$4.22B
| $358K | ﹤0.01% |
2,047
+828
| +68% | +$154K |
|
|
VIVO
2448
DELISTED
Meridian Bioscience Inc
VIVO
| $358K | ﹤0.01% |
18,966
-6,272
| -25% | -$117K |
|
2449
Albany International
AIN
$2.11B
| $357K | ﹤0.01% |
+4,850
| New | +$306K |
|
2450
SPX Corp
SPXC
$11B
| $357K | ﹤0.01% |
+6,533
| New | +$328K |
|
Similar funds
HSBC Holdings's Q4 2020 Portfolio in Review
As of Q4 2020, HSBC Holdings held 3,211 positions worth $75B, up 20% from $62.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
HSBC Holdings deployed $4.49B of net new capital in Q4 2020, opening 504 new positions and adding to 1,404 existing holdings. Its largest new stake was WisdomTree Emerging Markets ex-State-Owned Enterprises Fund: 1,581,494 shares worth $62.7M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Alibaba, an estimated $2.99B trimmed.
- HSBC Holdings's largest Q4 2020 buy was WisdomTree Emerging Markets ex-State-Owned Enterprises Fund: 1,581,494 shares worth $62.7M.
- HSBC Holdings added most to Apple in Q4 2020, an estimated $511M increase.
- HSBC Holdings's biggest Q4 2020 reduction was Alibaba, cutting an estimated $2.99B.
- HSBC Holdings fully exited TD Ameritrade Holding Corp in Q4 2020, selling an estimated $30.8M.
- HSBC Holdings's ten largest holdings make up 24% of its $75B portfolio in Q4 2020.
- HSBC Holdings opened 504 new positions and closed 192 in Q4 2020.
- HSBC Holdings's portfolio value rose 20% quarter-over-quarter to $75B.
Based on HSBC Holdings's 13F filing for Q4 2020, filed 12 Feb 2021.